30
Participants
Start Date
October 31, 2011
Primary Completion Date
November 30, 2012
Study Completion Date
January 31, 2013
CDX-301
"CDX-301, administered in multiple dosages and frequencies depending on arm:~n=3-6 at between 1-75 μg/kg over 5 days~n=3-6 at 25 μg/kg over 7 days~n=3-6 at 25 μg/kg over 10 days"
Rockefeller University, New York
Lead Sponsor
Celldex Therapeutics
INDUSTRY